ARS Pharmaceuticals, Inc.
Support and Resistance Levels
Past performance
News About SPRY
All events for SPRY
All deals for SPRY
Financial Ratios
Financial Statements
SPRY vs Sector & Peers
About ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California. Website ars-pharma.com
Headquarters San Diego, CA, US